NASDAQ:CLVS
Delisted

Clovis Oncology Stock News

etoro logo Buy CLVS
*Your capital is at risk
$0.151
+0 (+0%)
At Close: Apr 19, 2023

Will Eylea, Dupixent Buoy Regeneron's (REGN) Q1 Earnings?

04:21pm, Monday, 02'nd May 2022 Zacks Investment Research
Regeneron's (REGN) first-quarter performance might have gotten a boost from the solid performance of Eylea and Dupixent.

Is a Beat in Store for Zoetis (ZTS) This Earnings Season?

03:10pm, Monday, 02'nd May 2022 Zacks Investment Research
Zoetis (ZTS) is set to report earnings and revenue figures and provide updates on its pipeline when it releases first-quarter 2022 results.

DaVita (DVA) to Report Q1 Earnings: What's in the Offing?

02:01pm, Monday, 02'nd May 2022 Zacks Investment Research
Supply shortage along with pandemic-led incremental mortality rate is likely to have weighed on DaVita's (DVA) first-quarter top line.
Clovis (CLVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clovis: Shifting Toward Nuclear Medicine

12:33pm, Monday, 25'th Apr 2022
Clovis, a "trading stock," has some shakiness in its fundamentals. Moreover, the shares tend to rise and fall for you to trade for short-term gains. Due to upcoming catalysts in June, Clovis is a trad

Why Clovis Oncology Stock Fell 10.5% on Monday

08:51pm, Monday, 18'th Apr 2022 The Motley Fool
Clovis' shares dropped early in the day then rallied.

Why Clovis Oncology Stock Fell 10.5% on Monday

04:51pm, Monday, 18'th Apr 2022
Clovis' shares dropped early in the day then rallied.
Can these penny stocks continue to climb after a bearish trading day? The post Best Penny Stocks to Watch After the Stock Market Takes a Bear Turn appeared first on Penny Stocks to Buy, Picks, News an
Can these penny stocks continue to climb after a bearish trading day? The post Best Penny Stocks to Watch After the Stock Market Takes a Bear Turn appeared first on Penny Stocks to Buy, Picks, News an

Clovis (CLVS) Up 24% on Upbeat Data From Ovarian Cancer Study

07:11pm, Monday, 04'th Apr 2022 Zacks Investment Research
Clovis Oncology's (CLVS) stock price rises after it reports favorable data from a late-stage study on Rubraca as the first-line maintenance treatment of ovarian cancer.
Clovis Oncology's (CLVS) stock price rises after it reports favorable data from a late-stage study on Rubraca as the first-line maintenance treatment of ovarian cancer.

Trading Penny Stocks & What You Need to Know in April 

09:30pm, Sunday, 03'rd Apr 2022 PennyStocks
What you need to know about trading penny stocks in April The post Trading Penny Stocks & What You Need to Know in April  appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
What you need to know about trading penny stocks in April The post Trading Penny Stocks & What You Need to Know in April  appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Short squeeze stocks to watch in April The post Top Penny Stocks To Buy Under $5? 4 Short Squeeze Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
Short squeeze stocks to watch in April The post Top Penny Stocks To Buy Under $5? 4 Short Squeeze Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE